Table I.
Clinical factors | Group | N (%) |
---|---|---|
Age | ≤60 years | 26 (17.1) |
>60 and ≤70 years | 79 (52.0) | |
>70 years | 47 (30.9) | |
Gleason score | ≤6 | 78 (51.3) |
7 | 49 (32.2) | |
>7 | 25 (16.4) | |
PSA | <10 ng/ml | 67 (44.1) |
10-20 ng/ml | 36 (23.7) | |
>20 ng/ml | 48 (31.6) | |
Missing | 1 (0.7) | |
Smoking | No | 76 |
Yes | 76 | |
ZUBROD | 0 | 116 (76.3) |
1 | 35 (23.0) | |
2 | 1 (0.7) | |
Co morbid conditions | Yes | 92 (60.5) |
Diabetes | 8 (5.3) | |
Hypertension | 68 (44.7) | |
Cardiological diseases | 36 (23.7) | |
Cancer in family history | 68 (44.7) | |
Treatment | Surgery | 21 (13.8) |
Radical radiotherapy | 124 (81.6) | |
Cyberknife treatment | 13 (8.6) | |
Hormonotherapy | 125 (82.2) |
PSA, prostate-specific antigen; ZUBROD, performance scale.